These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Comparison between the role of intraoperative mitomycin C and doxorubicin in preventing the recurrence of primary pterygium. Sodhi PK; Verma L; Pandey RM; Ratan S Ophthalmic Res; 2005; 37(1):1-6. PubMed ID: 15604592 [TBL] [Abstract][Full Text] [Related]
28. Indications for and complications of mitomycin-C in pterygium surgery. Anduze AL; Burnett JM Ophthalmic Surg Lasers; 1996 Aug; 27(8):667-73. PubMed ID: 8858632 [TBL] [Abstract][Full Text] [Related]
29. Late complications after pterygium excision with high dose mitomycin C instillation. Hayasaka S; Iwasa Y; Nagaki Y; Kadoi C; Matsumoto M; Hayasaka Y Br J Ophthalmol; 2000 Sep; 84(9):1081-2. PubMed ID: 11032448 [No Abstract] [Full Text] [Related]
30. Management of recurrent pterygium with intraoperative mitomycin C and conjunctival autograft with fibrin glue. Shehadeh-Mashor R; Srinivasan S; Boimer C; Lee K; Tomkins O; Slomovic AR Am J Ophthalmol; 2011 Nov; 152(5):730-2. PubMed ID: 21742307 [TBL] [Abstract][Full Text] [Related]
31. Corneal and conjunctival findings after mitomycin C application in pterygium surgery: an in-vivo confocal microscopy study. Zhivov A; Beck R; Guthoff RF Acta Ophthalmol; 2009 Mar; 87(2):166-72. PubMed ID: 18537935 [TBL] [Abstract][Full Text] [Related]
32. Intraoperative mitomycin C versus autologous conjunctival autograft in surgery of primary pterygium with four-year follow-up. Koranyi G; Artzén D; Seregard S; Kopp ED Acta Ophthalmol; 2012 May; 90(3):266-70. PubMed ID: 20528781 [TBL] [Abstract][Full Text] [Related]
34. Pterygium surgery with mitomycin and tarsorrhaphy. Wood TO; Williams EE; Hamilton DL; Williams BL Trans Am Ophthalmol Soc; 2005; 103():108-14; discussion 114-5. PubMed ID: 17057794 [TBL] [Abstract][Full Text] [Related]
35. Intraoperative application of topical mitomycin C 0.05% for pterygium surgery. Rodriguez JA; Ferrari C; Hernández GA Bol Asoc Med P R; 2004; 96(2):100-2. PubMed ID: 15580913 [TBL] [Abstract][Full Text] [Related]
36. Comparison of intra-operative 0.02% mitomycin C and sutureless limbal conjunctival autograft fixation in pterygium surgery: five-year follow-up. Jiang J; Gong J; Li W; Hong C Acta Ophthalmol; 2015 Nov; 93(7):e568-72. PubMed ID: 25573636 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of limbal conjunctival autograft and low-dose mitomycin C in the treatment of recurrent pterygium. Nabawi KS; Ghonim MA; Ali MH Ophthalmic Surg Lasers Imaging; 2003; 34(3):193-6. PubMed ID: 12757091 [TBL] [Abstract][Full Text] [Related]
38. Comparison of Two Techniques for the Treatment of Recurrent Pterygium: Amniotic Membrane vs Conjunctival Autograft Combined with Mitomycin C. Katırcıoglu YA; Altiparmak U; Engur Goktas S; Cakir B; Singar E; Ornek F Semin Ophthalmol; 2015; 30(5-6):321-7. PubMed ID: 24506693 [TBL] [Abstract][Full Text] [Related]
39. Fungal scleral keratitis and endophthalmitis following pterygium excision. Peponis V; Rosenberg P; Chalkiadakis SE; Insler M; Amariotakis A Eur J Ophthalmol; 2009; 19(3):478-80. PubMed ID: 19396799 [TBL] [Abstract][Full Text] [Related]
40. Conjunctival autografting combined with low-dose mitomycin C for prevention of primary pterygium recurrence. Frucht-Pery J; Raiskup F; Ilsar M; Landau D; Orucov F; Solomon A Am J Ophthalmol; 2006 Jun; 141(6):1044-1050. PubMed ID: 16546105 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]